# Identification of Some Glutamic Acid Derivatives with Biological Potential by Computational Methods
## Abbreviations  
* [1] Ageing as an Important Risk Factor for Cancer | Anticancer Research. Available online: [[https://ari.iarjournals.org/content/36/1/0/5009.long](https://ari.iarjournals.org/content/36/1/0/5009.long)]([https://ari.iarjournals.org/content/36/1/0/5009.long](https://ari.iarjournals.org/content/36/1/0/5009.long)) (accessed on 25 January 2023). * [2] [PERSON]; [PERSON]; [PERSON] Ageing and Cancer: A Research Gap to Fill. _Mol. Oncol._**2022**, _16_, 3220-3237. [CrossRef]
* [3] Risk Factors: Age--NCI. Available online: [[https://www.cancer.gov/about-cancer/causes-prevention/risk/age](https://www.cancer.gov/about-cancer/causes-prevention/risk/age)]([https://www.cancer.gov/about-cancer/causes-prevention/risk/age](https://www.cancer.gov/about-cancer/causes-prevention/risk/age)) (accessed on 25 January 2023). * [4] American Cancer Society. _Global Cancer Facts & Figures_, 4 th ed. ; American Cancer Society: Atlanta, GA, USA, 2018; Available online: [[https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures-4](https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures-4) th-edition.pdf]([https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures-4](https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures-4) th-edition.pdf) (accessed on 13 January 2023). * [5] [PERSON]; [PERSON]; [PERSON]; [PERSON] Amino Acids in Cancer. _Exp. Mol. Med._**2020**, _52_, 15-30. [CrossRef]
* [6] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Biosynthetic Energy Cost for Amino Acids Decreases in Cancer Evolution. _Nat. Commun._**2018**, \(9\), 4124. [CrossRef]
* [7] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Uncovering the Role of N-Acetyl-Aspartyl-Clutamate as a Glutamate Reservoir in Cancer. _Cell Rep._**2019**, _27_, 491-501.e6. [CrossRef]
* [8] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Pharmacologic or Genetic Targeting of Glutamine synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis. _Cell Rep._**2017**, _20_, 1654-1666. [CrossRef]
* [9] [PERSON]; [PERSON]; [PERSON] Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster? _Cancers_**2019**, _11_, 804. [CrossRef]
* [10] [PERSON]; [PERSON] Glutamine Metabolism in Brain Tumors. _Cancers_**2019**, _11_, 1628. [CrossRef]
* [11] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Glutaminase Inhibitor CB-839 Increases Radiation Sensitivity of Lung Tumor Cells and Human Lung Tumor Xenografts in Mice. _Int. J. Radiat. Biol._**2019**, _95_, 436-442. [CrossRef]
* [12] [PERSON]; [PERSON] The Many Roles of Glutamate in Metabolism. _J. Ind. Microbiol. Biotechnol._**2016**, _43_, 419-430. [CrossRef]* [PERSON] et al. (2020) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. A Powerful Drug Combination Strategy Targeting Glutamine Addiction for the Treatment of Human Liver Cancer. _cLife_**2020**, \(9\), e56749. [CrossRef]
* [PERSON] et al. (2019) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy. _Cell Metab._**2019**, _29_, 124-140.e10. [CrossRef]
* [PERSON] (2019) [PERSON]; [PERSON] [PERSON]; [PERSON]-X. The Pleiotropic Effects of Glutamine Metabolism in Cancer. _Cancers_**2019**, _11_, 770. [CrossRef]
* [PERSON] et al. (2021) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Selective Glutamine Metabolism Inhibition in Tumor Cells Improves Antitumor T Lymphocyte Activity in Triple-Negative Breast Cancer. _J. Clin.